Poland· PL-100543580
Obsidan
A medicinal product containing ferrosi sulfas heptahydricus, registered in Poland by InPharm Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Ferrosi sulfas heptahydricus
- Manufacturer
- InPharm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991607463
- gtin05909991607470
- gtin05909991607487
- gtin05909991607494
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ferrosi sulfas heptahydricus in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomActiFerr-S 200mg tabletsMaN Pharma Ltd
- United StatesFerrous SulfateRichmond Pharmaceuticals Inc.
- BelgiumFero-Gradumet 525 mgTeofarma
- FranceFER AP-HP 0,5 mg NOUVEAU-NE, géluleASSISTANCE PUBLIQUE - HOPITAUX DE PARIS - AP-HP
- NorwayDuroferonPerrigo Sverige AB
- FinlandMicroferPfizer Health Ab
- GermanyEisensulfat LomapharmLomapharm Gmbh
- ItalyFERRO-GRAD*40 cpr 105 mg rilascio prolungatoTEOFARMA Srl
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Ferro - Gradumet
- Belgium · Fero-Gradumet
- Germany · Eisensulfat Lomapharm, Ferro Aiwa
- Spain · Ferogradumet
- France · Fer Nouveau-Ne Ap-Hp
- United Kingdom (Northern Ireland) · Feospan, Ferrous Sulfate Wockhardt Uk
- Greece · Tardyferon
- Hungary · Ferro-Gradumet
- Lithuania · Tardyferon
- Luxembourg · Fero-Gradumet
- Norway · Duroferon, Ferromax
- Portugal · Ferro-Gradumet
- Slovakia · Tardyferon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a077a775-da0a-4984-bbb3-9ee56bc1aec5 GET /v1/drugs/a077a775-da0a-4984-bbb3-9ee56bc1aec5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki dojelitowe, twarde",
"source": "urpl",
"strength": "100 mg jonów żelaza (Fe2+)",
"packaging": "05909991607463 ¦ Rp ¦ 168132\n30 tabl.\n05909991607470 ¦ Rp ¦ 168133\n50 tabl.\n05909991607487 ¦ Rp ¦ 168134\n90 tabl.\n05909991607494 ¦ Rp ¦ 168135\n100 tabl.",
"substance": null,
"common_name": "Ferrosi sulfas heptahydricus",
"pl_product_id": "100543580",
"pozwolenie_nr": "288/26",
"auth_procedure": "IR",
"authorisation_validity": "2031-08-10"
}See everything about ferrosi sulfas heptahydricus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.